Patents
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
04/2008
04/30/2008EP1915171A2 Method of preserving the function of insulin-producing cells
04/30/2008EP1915170A1 Use of neuropilin-2 antagonists
04/30/2008EP1915169A2 Pharmaceutical compositions comprising a tgf-beta superfamily member
04/30/2008EP1915168A2 Ligands of melanocortin receptors
04/30/2008EP1915167A2 Melanocortin receptor ligands
04/30/2008EP1915162A1 Modulators
04/30/2008EP1915060A2 Process for controlling protein to salt ratio in animal muscle protein composition and protein composition reference to related application
04/30/2008EP1664093B1 Antitumoral compounds based on Kahalalide F
04/30/2008EP1549670B1 Template-fixed peptidomimetics with antimicrobial activity
04/30/2008EP1458240B1 Nucleic acid constructs useful for glucose regulated production of human insulin in somatic cell lines
04/30/2008EP1419177B1 A purification process for large scale production of gc-globulin, product obtained thereby and their use in medicine
04/30/2008EP1406651B1 Cosmetic or dermatological use of a peptide for promoting adhesion between skin cells
04/30/2008EP1399023B1 COMPOSITIONS FOR SYSTEMIC ADMINISTRATION OF SEQUENCES ENCODING BONE MORPHOGENETIC PROTEINS& x9;
04/30/2008EP1307486B1 Somatostatin analogues
04/30/2008EP1294747B1 Synthetic methods for aplidine and new antitumoral derivatives, methods of making and using them
04/30/2008EP1213297B1 Tachykinin peptides, precursor peptides thereof and genes encoding the same
04/30/2008EP1212417B1 Promotion or inhibition of angiogenesis and cardiovascularization
04/30/2008EP1208116B1 Somatostatin analogs, radiolabelled derivatives thereof and their use
04/30/2008EP1183360B1 Modified cytokine for its stabilisation
04/30/2008EP1173471B1 Pseudomycin analogs
04/30/2008EP1165613B1 Melanocortin receptor ligands
04/30/2008EP1159430B1 Histidin protein-phosphatase
04/30/2008EP1127072B1 Method for detecting and purifying tcd8+ lymphocyte populations, specific of peptides present in the context of hla
04/30/2008EP1058728B1 V-like domain binding molecules
04/30/2008EP0981360B1 Method for preventing gastritis using amylin or amylin agonists
04/30/2008EP0730657B1 Composition for the in vivo production of therapeutic products
04/30/2008DE102006050672A1 New glycylglycine derivatives with a benzylsulfonylamido group and an amidino-organylamido group at the opposite chain ends, used in drugs for reducing loss of blood, e.g. in operations
04/30/2008CN101171332A Materials and methods for regulating blood flow
04/30/2008CN101171262A Glucagon-like-peptide-2 (GLP-2) analogues
04/30/2008CN101171035A Methods and compositions for modulating TWEAK and FN14 activity
04/30/2008CN101171032A Use of native peptides and their optimized derivatives for vaccination
04/30/2008CN101171030A Use of plasmin for preventing of reducing the rate of the progression of non-proliferative diabetic retinopathy and the treatment of other ocular conditions
04/30/2008CN101171029A Agent for treating and/or preventing of neuropathic pain
04/30/2008CN101171028A Use of fibrous tissue inducing proteins for hernia repair
04/30/2008CN101171027A Use of histones for therapeutic purposes
04/30/2008CN101171026A Health food and pharmaceutical composition for amelioration of disease induced by metabolic disorder in cartilage
04/30/2008CN101171025A Novel nutraceutical compositions
04/30/2008CN101171024A Blood pressure lowering protein hydrolysates
04/30/2008CN101171023A Particle and preparation containing the particle
04/30/2008CN101171022A Compositions and methods for inhibiting G protein signaling
04/30/2008CN101171021A Ejection liquid, ejection method, method for forming liquid droplets, liquid ejection cartridge and ejection apparatus
04/30/2008CN101168565A Nitric oxide-blocked cross-linked tetrameric hemoglobin
04/30/2008CN101168564A Human antibiotic peptide and use for derivative thereof
04/30/2008CN101168560A N-substituted peptide amide, pharmaceutical composition and use thereof
04/30/2008CN101168066A Method for making animal model simulated human cornea fungal infection
04/30/2008CN101168061A Biological degradable polymer-solid liposome sustained-release storing system and preparation method thereof
04/30/2008CN101168052A Enteric coated preparation for preventing and treating hyperuricemia and gout
04/30/2008CN101168051A Application of sea collagen peptide as preparation of anti-oxidation medicine, health-care food, food or cosmetics
04/30/2008CN101168050A Immunity regulating medicinal composition
04/30/2008CN101168049A Application of interleukin-22 in preparing medicine for treating hepatopathy and preparation method thereof
04/30/2008CN101168048A Application of cerebral tissue fluid and nerve growth factor in preparing combination medicine for treating infantile cerebral paralysis
04/30/2008CN101168047A Composition with radiation-proof, anti-oxidation and DNA-protection effects and use
04/30/2008CN101168046A Traditional Chinese medicine ointment for treating chronic rhinitis
04/30/2008CN101168045A Application of sea protein peptide as preparation of radiation-proof medicine, health-care food or food
04/30/2008CN101168044A Product formula for lady daily nursing gel
04/30/2008CN101167929A Method for producing high-density lipoprotein biological regulator
04/30/2008CN101167754A Application of sea bone peptide in preparing medicine, health-care food or food for preventing osteoporosis
04/30/2008CN101167753A Application of sea collagen peptide as preparation of hypoglycemic medicine, health-care food or food
04/30/2008CN101167704A Nosiheptide taste-masked microcapsule and preparation method thereof
04/30/2008CN101167699A Insulin sustained-release oral preparation and preparation method thereof
04/30/2008CN100385005C Methods for the production of multimeric proteins, and related compositions
04/30/2008CN100385002C Di- or oligomer of a dimer, trimer, quatrometer or pentamer of recombinant fusion proteins
04/30/2008CN100384991C High purity kallidinogenase prepartion method and its pharmaceutical formulation
04/30/2008CN100384894C Higher molecular modifier and medicinal composition
04/30/2008CN100384880C Modified peptides as therapeutic agents
04/30/2008CN100384879C Modified peptides as therapeutic agents
04/30/2008CN100384878C Antibodies specific for human cd22 and their therapeutic anddiagnostic uses
04/30/2008CN100384875C 蛋白质 Protein
04/30/2008CN100384873C Chimeric antagonist ANTH1
04/30/2008CN100384480C Delivery system for nucleic acids
04/30/2008CN100384472C Antigen-specific lgE antibody production inhibitors
04/30/2008CN100384471C Albumin solution and method for the production thereof
04/30/2008CN100384470C Compound steam cell medicine, its preparing process and its application
04/30/2008CN100384469C Treatment of pulmonary disease
04/30/2008CN100384468C L-methionine as a stabilizer for NESP/EPO in hsa-free formulations
04/30/2008CA2564924A1 Design of interferon-inducible protein-10 (ip-10 or cxcl10) chemokine analogs for the treatment of human diseases
04/29/2008US7365178 Acyl-nucleotide probes and methods of their synthesis and use in proteomic analysis
04/29/2008US7365175 Wit 3.0, a novel gene to control soft tissue wound healing
04/29/2008US7365172 Cytoprotective agent to protect a patient undergoing cancer cytotoxic therapy from gastrointestinal side effects; peptide that is derived from a loop or "lollipop" region of transforming growth factor; stimulate hematopoiesis; diabetes, rheumatoid arthritis, lupus, and multiple sclerosis
04/29/2008US7365171 Chemotactic cytokine for use in diagnosis, prevention and treatment of tumors
04/29/2008US7365170 Reagents for regulation of metabolic events, such as those mediated by adiponectin and adiponectin agonists. The invention also provides screening assays for identification of biologically active agents, diagnostic and therapeutic agents
04/29/2008US7365169 T-bet antibodies
04/29/2008US7365165 Suitable for lyophilization, protein capable of binding and inhibiting the biological action of IL-1,histidine, glycine, arginine, sucrose, stability; resistant to degradation, aggregation, oxidation, and other degenerative processes while in the freeze dried state
04/29/2008US7365162 Stabilized bioactive peptides and methods of identification, synthesis, and use
04/29/2008US7365159 Plasminogen fragments containing kringle region domains having anti-angiogenic activity and terned angiostatin protein. The plasminogen fragments of the present invention may be used for the treatment of angiogenesis-dependent diseases such as
04/29/2008US7365155 Immunoregulator
04/29/2008US7365154 Use as an immunogen to generate anti-integrin antibodies; a mimotope; vaccinating against angiogenic and metastatic diseases
04/29/2008US7365153 Biologically active peptide and agent containing the same
04/29/2008US7365092 Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
04/29/2008US7365054 Methods for treatment of tumors and metastases using a combination of anti-angiogenic and immuno therapies
04/29/2008US7365053 Staphylococcal infection; controlling the growth of a microorganism
04/29/2008US7365052 Tendon-inducing methods
04/29/2008US7365051 Compounds with improved cartilage-inducing and/or bone-inducing activity
04/29/2008US7365050 Using calcium channel blockers
04/29/2008US7365049 Afamin-containing compositions and methods of use
04/29/2008US7365047 Injecting pentagastrin and a gastrin, with gastric proton pump inhibitor effective to reduce gastric acid secretion
04/29/2008US7364910 Methods of inducing ovulation
04/29/2008US7364896 Test strips including flexible array substrates and method of hybridization
04/29/2008US7364889 Catalytically active peptides
04/29/2008US7364888 Intratracheal administration of lysozyme with other therapeutic agents in the prevention and treatment of respiratory disorders